Before the arrival of the Corona vaccine, the Priority Group has been finalized in India. In the first phase, 31 crore people will be vaccinated. These include healthcare workers, police, priority group members above 50 years of age, and youth from high-risk groups. The government has also decided that the initial data from two full-shot results from two-dose trials of the Oxford-AstraZeneca vaccine will be considered.
Blueprint for vaccine preparation
Principal Scientific Advisor K. According to Vijayaraghavan, the National Vaccine Committee headed by Dr. VK Paul has prepared a blueprint for who will be the first to be vaccinated. He told a meeting of the Ministry of Science and The Confederation of Indian Industry (CII) that 31 crore people have been identified, who will be vaccinated between March and May.
Vijayaraghavan said, 'One crore health workers in our country, 2 crore of state and central government police, armed forces, home guards, civil defense, 26 crore members of priority group over 50 years of age and below 50 years 1 crore members of the high-risk group will be the first to be vaccinated. Earlier, Union Health Minister Harsh Vardhan has said that the vaccine will start from the first quarter of 2021. 25 crore people are ready to be vaccinated. 40-50 crore doses will be available by July.
What data will Oxford consider India?
Phase 3 or final phase trials of the Corona Vaccine Coveshield of Oxford University-AstraZeneca have yielded results. On giving two full doses, the FICCI was 62% and when given one half and one full dose, the FICC was 90 percent. On which of these two formulas the data will be considered in India, the head of the National Vaccine Committee, Dr. VK Paul has said that the regulators are examining the data. Whatever decision will be taken will be on a scientific basis. It is not right to make public debate on this data is confidential. At the same time, some other Indian officials say that the American Food and Drug Administration (USFDA) has required at least 50% efficacy to approve the vaccine. In this case, the results of two full dosage formulas are also good.
European Union will take its first vaccine this year
European Union leaders expect the first vaccine to be introduced in December. By the way, the European Medicines Agency, without naming any company, said that in the next few days, some companies can apply for approval. Pfizer and Biotech are at the forefront of the regulatory approval process. Apart from Pfizer, American company Moderna and British company AstraZeneca and Oxford University have also announced the results of Phase-3 trials of their vaccine. Pfizer has also applied for approval in the US. The process of applying the vaccine to high-risk patients has already started even before the results of Phase-3 trials in China and Russia. For this, China has given emergency approval to four vaccines and Russia two.
UK regulator will investigate the results of the Oxford vaccine
The British government has formally asked the country's drug regulator to examine the Phase-3 results of AstraZeneca and Oxford University's vaccine-Kovyshield. The British government has taken this step amid questions arising over the initial results of the trials. Earlier, the UK government had also instructed the medical regulator to check the efficacy of Pfizer's vaccine. The drug regulator says that any vaccine will be approved even after meeting the criteria on the issue of safety, quality, and affixation.
AstraZeneca will conduct a new global clinical trial
AstraZeneca said it would conduct a global clinical trial to see its vaccine affixation. However, regulatory approval in the UK or EU will not be delayed. There may be a delay in seeking approval from the USFDA for vaccines in the US. During the trials, 2,741 volunteers received half + one dose, while 8,895 people received two full doses. In such a situation, the company faced difficulties in proving effectiveness in the group.
Russian vaccine will remain effective with Oxford vaccine
Russia's Gamalaya Research Institute has claimed that its Sputnik V vaccine may increase Astyzyneca-Oxford's CoviShield's Efficacy. Gamalaya Institute said on social media - "Oxford's two full dose affixes have been 62%. If new clinical trials begin, we suggest Sputnik V Human Adenoviral Vector Shot with Kovyshield, this will increase the Efficiency Two. Adding the vaccine can lead to significant re-vaccination results. "
Pfizer vaccine will be approved in Canada in December
Canadian drug regulator, Health Canada, has said it will approve Pfizer-BioNotech's COVID-19 vaccine around December. Supriya Sharma, Senior Medical Advisor at Health Canada, said that the vaccine has been at the forefront of Health Canada's review. A final decision on Pfizer's vaccine may also be taken in Canada's neighboring country of America in December and it can be approved for emergency use.
Hardik Pandya gave a very accurate answer to the future of captaincy - if given a chance...
Hardik Pandya had become a villain in the eyes of Indian cricket fans since the way Team India lost the first two matches in the T20 World Cup 2021. Hardik has made himself a hero from a villain in
May heat in March: Hot winds coming from Pakistan started heating up; the Heatwave continues even in the foothills of Himachal; Know what experts say
When the month of March started, there was a slight cold left, but around Holi, the mercury suddenly started skyrocketing. It has been so hot in March that the record of 121 years has been broken.
Coronavirus Guidelines: What are the rules of isolation and quarantine if you are corona positive, know here
Coronavirus Guidelines: Corona cases in India have once again started increasing rapidly. In the last few days alone, more than 8 thousand cases are being seen daily. Which has raised the concern of
Realme GT 5G smartphone specifications and price leaked, this phone will compete
Chinese mobile phone company Realme is ready to launch its Realme GT 5G smartphone. It has already been launched in China. It is expected to be launched first in Europe and then in other markets
PM Modi said in Lumbini- Nepal is incomplete without our Ram, told its special relationship with Buddha
Narendra Modi Speech in Lumbini: PM Narendra Modi said in Lumbini, the birthplace of Mahatma Buddha, that without Nepal, even our Ram is incomplete. He said that if the Ram temple is being built in
Coronavirus Updates: Corona cases increased again in the country, with 2124 new patients in 24 hours, and 17 people died
The cases of corona infection have increased again in the country. A day later, the cases of corona have again crossed two thousand. The Health Ministry said that in the last 24 hours, 2,124 new cases
Lalu Prasad Yadav's condition worrisome, Delhi AIIMS will be shifted from Rims of Ranchi
New Delhi: The condition of RJD chief Lalu Prasad, who is serving a jail sentence in the fodder scam, is worrying. When the health worsened, doctors referred him from RIMS Hospital in Ranchi to AIIMS
Lumpy virus: Governments are not paying attention to genome sequencing, only Maharashtra sent samples after Rajasthan
After Rajasthan, now Maharashtra has also started genome sequencing regarding the lumpy virus, but the rest of the states are not paying any attention to it. Samples from every district of Rajasthan
These wireless headphones in the range of thousand rupees are making a splash, due to their powerful features, they are being sold quickly.
Amazon Deal On Earbuds: If you want to buy headphones with low latency for gaming so that outside sound is not heard or if you want to buy good bass earbuds for music, whose battery also lasts for 50
Taarak Mehta Ka Ooltah Chashmah: Finally the video of Dayaben's entry in 'Gokuldham' surfaced, the people of the society performed Garba in happiness
Taarak Mehta Ka Ooltah Chashmah News: The comedy show 'Taarak Mehta Ka Ooltah Chashmah' is the only show that people of all ages like to watch. The twists coming in the show work to keep the audience
